Crossmark Global Holdings’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,280
Closed -$210K 1289
2022
Q2
$210K Sell
4,280
-200
-4% -$10.7K 0.01% 1193
2022
Q1
$254K Buy
4,480
+140
+3% +$7.44K 0.01% 1210
2021
Q4
$228K Buy
4,340
+650
+18% +$35.3K 0.01% 1286
2021
Q3
$221K Hold
3,690
0.01% 1299
2021
Q2
$250K Sell
3,690
-70
-2% -$4.78K 0.01% 1273
2021
Q1
$247K Buy
3,760
+10
+0.3% +$600 0.01% 1271
2020
Q4
$211K Sell
3,750
-390
-9% -$19.2K 0.01% 1287
2020
Q3
$201K Sell
4,140
-10
-0.2% -$539 0.01% 1232
2020
Q2
$231K Buy
4,150
+170
+4% +$9.83K 0.01% 1167
2020
Q1
$202K Sell
3,980
-70
-2% -$4.69K 0.01% 1059
2019
Q4
$313K Sell
4,050
-80
-2% -$5.65K 0.01% 1094
2019
Q3
$262K Sell
4,130
-180
-4% -$11.3K 0.01% 1123
2019
Q2
$252K Sell
4,310
-199
-4% -$11.7K 0.01% 1174
2019
Q1
$256K Buy
4,509
+10
+0.2% +$532 0.01% 1195
2018
Q4
$223K Buy
4,499
+90
+2% +$5.41K 0.01% 1244
2018
Q3
$313K Sell
4,409
-30
-0.7% -$1.91K 0.01% 1279
2018
Q2
$231K Buy
4,439
+30
+0.7% +$1.57K 0.01% 1470
2018
Q1
$230K Sell
4,409
-169
-4% -$8.57K 0.01% 1433
2017
Q4
$268K Sell
4,578
-3,121
-41% -$177K 0.01% 1436
2017
Q3
$427K Buy
+7,699
New +$509K 0.01% 1068
2016
Q3
$427K Buy
+7,699
New +$490K 0.01% 1068

Other funds holding NUVA

Crossmark Global Holdings's NUVA Position: Q3 2022 in Review

Crossmark Global Holdings sold out of NuVasive, Inc. (NUVA) in Q3 2022, closing a stake of 4,280 shares — an estimated $210K sold.

Crossmark Global Holdings first reported a position in NUVA in Q3 2016 and held it in 21 quarters. The position peaked at $427K in Q3 2017. 232 funds tracked by Wall St. Rank hold NUVA as of Q3 2022.

  • Crossmark Global Holdings reported no remaining NuVasive, Inc. position as of Q3 2022 after selling out during the quarter.
  • Crossmark Global Holdings sold 4,280 NuVasive, Inc. shares in Q3 2022, an estimated $210K.
  • Crossmark Global Holdings first reported a position in NuVasive, Inc. in Q3 2016 and held it in 21 quarters.
  • Crossmark Global Holdings's NuVasive, Inc. position peaked at $427K in Q3 2017.
  • 232 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2022.

Based on Crossmark Global Holdings's 13F filing for Q3 2022, filed 1 Nov 2022.